Foodservice packaging supplier Karat Packaging (NASDAQ:KRT) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.4% year on year to $124.5 million. The company expects next quarter’s revenue to be around $113.8 million, coming in 1.7% above analysts’ estimates. Its non-GAAP profit of $0.37 per share was 5.1% below analysts’ consensus estimates.
Specialty insurance provider Palomar Holdings (NASDAQ:PLMR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 64.8% year on year to $244.7 million. Its non-GAAP profit of $2.01 per share was 24.8% above analysts’ consensus estimates.
Energy drink company Monster Beverage (NASDAQ:MNST) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 16.8% year on year to $2.20 billion. Its non-GAAP profit of $0.56 per share was 17.5% above analysts’ consensus estimates.
Healthcare solutions company Evolent Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 22.8% year on year to $479.5 million. On the other hand, next quarter’s revenue guidance of $467 million was less impressive, coming in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.05 per share was 52.5% below analysts’ consensus estimates.
Real estate technology company eXp World (NASDAQ:EXPI) announced better-than-expected revenue in Q3 CY2025, with sales up 6.9% year on year to $1.32 billion. Its GAAP profit of $0.02 per share was in line with analysts’ consensus estimates.
Cupertino, CA – November 6, 2025 – Amidst a turbulent financial landscape marked by a broader market downturn, large-cap technology stocks are demonstrating remarkable resilience and robust performance, with Apple (NASDAQ: AAPL) standing out as a prime example of this unwavering strength. While global indices, including the S&P 500, registered declines
Outdoor lifestyle and equipment company Clarus (NASDAQ:CLAR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 3.3% year on year to $69.35 million. Its non-GAAP profit of $0.05 per share was in line with analysts’ consensus estimates.
Golf entertainment and gear company Topgolf Callaway (NYSE:MODG) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales fell by 7.8% year on year to $934 million. The company expects next quarter’s revenue to be around $783 million, close to analysts’ estimates. Its non-GAAP loss of $0.05 per share was 76.9% above analysts’ consensus estimates.
New York, NY – November 6, 2025 – In a financial landscape often dominated by high-flying growth stocks, a steadfast segment of the market is quietly delivering impressive results, capturing the attention of income-driven investors. High Dividend Exchange Traded Funds (ETFs) are demonstrating remarkable resilience and performance, with the Fidelity High Dividend
Satellite communications provider Globalstar (NASDAQ:GSAT) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 2.1% year on year to $73.85 million. The company’s full-year revenue guidance of $272.5 million at the midpoint came in 2.9% above analysts’ estimates. Its GAAP loss of $0.01 per share was $0.02 above analysts’ consensus estimates.
Insurance solutions provider F&G Annuities & Life (NYSE:FG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.5% year on year to $1.69 billion. Its non-GAAP profit of $1.22 per share was 25.4% above analysts’ consensus estimates.
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales were flat year on year at $191.8 million. Its non-GAAP profit of $0.93 per share was 12.7% above analysts’ consensus estimates.
The U.S. stock market experienced a notable downturn today, November 6, 2025, as investors grappled with growing apprehension over the lofty valuations of artificial intelligence (AI) stocks and a significantly deteriorating job market. Major indices, including the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average, registered sharp
As of November 6, 2025, the energy sector is theoretically experiencing a robust upswing, capturing significant market attention. This hypothetical strong performance, with companies like Imperial Oil (TSX:IMO) at the forefront, underscores the sector's inherent volatility and its deep sensitivity to a confluence of global economic and geopolitical factors.
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of $2.88 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $1.18 per share was 53.4% above analysts’ consensus estimates.
After years of bubble-fueled “prosperity” funded by monetary inflation to the tune of five trillion dollars, American consumers appear to be running out of money.
The Artificial Intelligence (AI) sector is currently experiencing significant volatility, marked by a broader tech downturn, investor concerns over stretched valuations, and fears of a potential "AI bubble." Amidst this turbulent landscape, NVIDIA (NASDAQ: NVDA) has largely demonstrated sustained growth, reinforcing its indispensable role in the AI revolution. In stark
Senior living provider Brookdale Senior Living (NYSE:BKD) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 3.7% year on year to $813.2 million. Its GAAP loss of $0.48 per share was significantly below analysts’ consensus estimates.
Performance marketing company QuinStreet (NASDAQ:QNST) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.4% year on year to $285.9 million. The company expects next quarter’s revenue to be around $275 million, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.
Education finance company Nelnet (NYSE:NNI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 47.6% year on year to $427.8 million. Its GAAP profit of $2.94 per share was 93.4% above analysts’ consensus estimates.
Madison, WI – November 6, 2025 – First Business Bank (Nasdaq: FBIZ) has announced a quarterly cash dividend of $0.29 per share, a move that underscores the institution's commitment to shareholder returns while maintaining a strong financial footing. Declared by its Board of Directors today, November 6, 2025, this dividend is
FREMONT, CA – November 6, 2025 – Lam Research Corporation (Nasdaq: LRCX), a leading global supplier of innovative wafer fabrication equipment and services to the semiconductor industry, today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock. This declaration, coming on
Specialized equipment manufacturer for infrastructure and vegetation management Alamo Group (NYSE:ALG) announced better-than-expected revenue in Q3 CY2025, with sales up 4.7% year on year to $420 million. Its non-GAAP profit of $2.34 per share was 11.3% below analysts’ consensus estimates.
Genetic testing company Natera (NASDAQ:NTRA). reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 34.7% year on year to $592.2 million. The company’s full-year revenue guidance of $2.22 billion at the midpoint came in 6.1% above analysts’ estimates. Its GAAP loss of $0.64 per share was 74.5% below analysts’ consensus estimates.
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50 per share was 4.7% above analysts’ consensus estimates.
Fantasy sports and betting company DraftKings (NASDAQ:DKNG) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 4.4% year on year to $1.14 billion. The company’s full-year revenue guidance of $6 billion at the midpoint came in 3.1% below analysts’ estimates. Its non-GAAP loss of $0.26 per share was in line with analysts’ consensus estimates.
Smart property technology provider Alarm.com (NASDAQ:ALRM) announced better-than-expected revenue in Q3 CY2025, with sales up 6.6% year on year to $256.4 million. Its non-GAAP profit of $0.76 per share was 24.3% above analysts’ consensus estimates.
Analog chipmaker Microchip Technology (NASDAQ:MCHP) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 2% year on year to $1.14 billion. On the other hand, next quarter’s revenue guidance of $1.13 billion was less impressive, coming in 4.3% below analysts’ estimates. Its non-GAAP profit of $0.35 per share was 4.9% above analysts’ consensus estimates.
Dallas, TX – November 6, 2025 – Globe Life Inc. (NYSE: GL), a prominent player in the life and health insurance industry, recently distributed its quarterly dividend of $0.2700 per share, reinforcing its commitment to shareholder returns. The payment, made on October 31, 2025, marks a continuation of the company's policy
Financial automation software company BlackLine (NASDAQ:BL) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.5% year on year to $178.3 million. The company expects next quarter’s revenue to be around $183 million, close to analysts’ estimates. Its non-GAAP profit of $0.51 per share was in line with analysts’ consensus estimates.
Dallas, TX – November 6, 2025 – Valhi, Inc. (NYSE: VHI), a diversified holding company, has declared its regular quarterly dividend of $0.08 per share on its common stock. This announcement, made on November 6, 2025, with a record date of November 21, 2025, and a payment date of December 18,
Wellness products company Nature’s Sunshine (NASDAQ:NATR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12% year on year to $128.3 million. The company’s full-year revenue guidance of $478 million at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was significantly above analysts’ consensus estimates.
Internet, cable TV, and phone provider Cable One (NYSE:CABO) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 4.5% year on year to $376 million. Its GAAP profit of $14.52 per share was 94.5% above analysts’ consensus estimates.
Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance ($156 million at the midpoint) was surprisingly good and 3.5% above what analysts were expecting. Its GAAP loss of $0.22 per share was 22.3% above analysts’ consensus estimates.
